Abstract The ubiquitous Candida spp. is an opportunistic fungal pathogen which, despite treatment with antifungal drugs, can cause fatal bloodstream infections (BSIs) in immunocompromised and immunodeficient persons. Thus far, several major C. albicans virulence factors have been relatively well studied, including morphology switching and secreted degradative enzymes. However, the exact mechanism of Candida pathogenesis and the host response to invasion are still not well elucidated. The relatively recent discovery of the quorum-sensing molecule farnesol and the existence of quorum sensing as a basic regulatory phenomenon of the C. albicans population behavior has revolutionized Candida research. Through population density regulation, the quorum-sensing mechanism also controls the cellular morphology of a C. albicans population in response to environmental factors, thereby, effectively placing morphology switching downstream of quorum sensing. Thus, the quorum-sensing phenomenon has been hailed as the 'missing piece' of the pathogenicity puzzle. Here, we review what is known about Candida spp. as the etiological agents of invasive candidiasis and address our current understanding of the quorum-sensing phenomenon in relation to virulence in the host.
Invasive candidiasis
Invasive candidiasis (also known as systemic candidiasis or hematogenously disseminated candidiasis) involves the infection and spread of Candida via the bloodstream to multiple organs, such as the brain, kidneys, heart, lungs, and liver [7] . Immunocompromised and immunodeficient persons, such as those with diabetes, neutropenia, burns, persons with intravascular catheters, patients undergoing hemodialysis, abdominal surgery, and total parenteral nutrition, and those under prolonged therapy with broad-spectrum antibiotics or corticosteroids, are particularly susceptible to C. albicans candidiasis [8] . Antifungal resistance is a growing menace [9] , resulting in difficulty in treating and eliminating Candida invasive infections.
More than 17 different species of Candida are reported to cause invasive candidiasis in humans [10] . C. albicans is the most common species worldwide, representing a global average of 66% of all Candida species (see Table 1 ), even though other species of Candida are increasing in prevalence [11] . However, the frequency of C. albicans occurrence as the dominant species varies around the world, from 37% in Latin America to 70% in Norway [11] .
Disconcertingly, the incidence of invasive candidiasis is on the rise with the population increase of susceptible individuals, and treatment is hampered by antifungal resistance. According to Pendrak et al. [12] , cases of invasive candidiasis have increased ten-fold within the past decade and Candida spp. have now become the third most prevalent cause of bloodstream infections (BSIs). The fourth most common cause of nosocomial (hospitalacquired) BSIs in the USA is Candida spp., accounting for 8-10% of all nosocomial BSIs [13] , resulting in high personal and government treatment costs [14] . It is estimated that two out of every three Candida BSIs are nosocomial [15] , and the total annual burden of candidemia in the USA is about 10,500-42,000 cases [11] .
Candida bloodstream and systemic infections have a high mortality rate of 46-75% [13] and high morbidity in patients who survive the infection [16] . C. albicans intraabdominal infections in liver-transplant patients have a mortality rate of up to 60% [17, 18] .
There are few detailed epidemiological studies in Asian countries. An epidemiological study in Hong Kong by Yap et al. [19] found that C. albicans was the most commonly identified species (with an average of 56%) in Candida BSI cases from 1998 to 2006. C. albicans is still the highest cause of Candida BSIs in Singapore (33.3%), Taiwan (55.6%), and Japan (41%), according to reports by Yang et al. [20] , Cheng et al. [21] , and Takakura et al. [22] , respectively. However, in Thailand, C. parapsilosis had a slightly higher incidence (45%) than C. albicans (44.5%) [23] , while in Malaysia, C. parapsilosis and C. tropicalis are the major etiological agents, followed by C. albicans, with only 11.76% of candidemia cases [24] . 
Secreted degradative enzymes
Two large families of secreted degradative enzymes, of which some members have been associated with invasion, are the secreted aspartyl proteinases (SAP) and phospholipases (PL). Four PLs have been identified thus far (PLA, PLB, PLC, and PLD), although only PLB1 has been shown to be necessary for virulence and was detected at the tips of hyphae during tissue invasion [36] . The SAP family, which consists of at least ten genes [37] , is differentially expressed at various stages of infection.
Morphology switching
C. albicans is a polymorphic diploid fungus that is able to undergo morphogenic (or morphology) switching from the unicellular budding yeast forms (blastospores) to the filamentous forms (hyphae and pseudohyphae). Figure 1 shows examples of these morphologies as seen under a light microscope. Yeast cells are round or ovoid in shape and readily separate. Yeast cells can be cultured below 37°C or pH 4, or at cell densities of more than 10 7 cells/mL. Pseudohyphal cells resemble elongated yeast cells that remain attached to each other, usually growing in a branching pattern. True hyphae grow in the presence of serum at 37°C and pH 7. Pseudohyphal and true hyphal cells can be very similar when observed using light microscopy. True hyphal cells are long and highly polarized, with parallel sides (width ∼2 μm) and no obvious constrictions between cells. However, pseudohyphae have constricted septal junctions between cells, with thicker, unparallel sides (width ≥2 μm). Because it was generally thought that pseudohyphae physiology resembles yeast more than hyphae [26, 38] , few studies were devoted to the role of pseudohyphal forms in pathogenicity and virulence. Other species of Candida, except for C. albicans and C. dubliniensis, do not form true hyphae, but grow as pseudohyphae instead. However, with the rising incidence of these other species in systemic candidiasis [11] , the possibility that pseudohyphae may also be important in pathogenesis cannot be ruled out. Germ tubes, which can be seen after 30-60 min of incubation in hyphae-inducing conditions, are the precursors of true hyphal growth. After several hours of hyphae development, branched mycelia will form, and, if a suitable surface is available, biofilm formation can be seen by 24 h.
The ability of C. albicans to switch between the yeast and filamentous forms is considered to be crucial for virulence, but very little is understood about the roles of the three major morphological forms, especially the pseudohyphal form, in infection. Conventional views are that the yeast form is useful for disseminating the fungus in the bloodstream, whilst the filamentous forms, especially the hyphae form, have the ability to penetrate host barriers [6, 39] and present a way that the fungus can adapt to and take advantage of different host niche conditions. Recent studies have even suggested that it is not the morphological form per se, but, rather, the ability to undergo the morphology switching process, which is a virulence factor [40, 41] .
Although the exact mechanism of this morphogenesis has yet to be fully understood, the signaling pathways that translate environmental signals into morphology switching have been well studied [42] [43] [44] .
Disruptions of the genes EFG1 and CPH1 result in a C. albicans double mutant that is incapable of hyphae formation, even in the presence of serum, and is avirulent in a mouse model as well [42] . This suggests that the combined pathways activated by EFG1 and CPH1 are responsible for filamentation. However, this double mutant could still filament under embedded conditions [31] . The Rim101 pathway, dependent on Efg1, mediates pH response [45] , while response to embedding in a solid matrix is mediated by a pathway that activates Czf1 [31] .
The Nrg1-Rpg1-Tup1 pathway and the Rbf1 pathway are two negative regulatory pathways that inhibit yeastfilament switching [40, [46] [47] [48] [49] [50] [51] and the deletion of TUP1 resulted in hyphae development [46] . Despite being locked in the hyphal form, this mutant was avirulent in a mouse model of systemic candidiasis [47] .
Morphology switching in the presence of serum at 37°C and pH 7 is a special characteristic of C. albicans. Switching via serum induction is able to occur via one of the multiple pathways involved, although Feng et al. [52] observed that serum-induced yeast-hyphae transition requires the Ras signaling pathway.
Hyphae-specific genes (HSGs) are genes that are induced during hyphae development when at least two environmental conditions are present, for example, a temperature of 37°C and the presence of serum [53] . Several HSGs found thus far include the SAP genes (SAPs 4, 5, 6), which encode the secreted aspartyl proteases, HWP1 (cell wall proteins), and the adhesins ALS3 and ALS8 [47, 53] . However, none of these HSGs are actually required for filamentation but are induced because they are targets of the morphogenesis pathways [26] .
The first true HSG that is critically required for hyphae development was discovered by Zheng et al. [54] . HGC1 deletion repressed not only hyphae formation under various conditions, but virulence as well. However, the authors found that HGC1 expression alone was insufficient to initiate hyphae formation, suggesting that HGC1 does not control hyphae formation and that other unknown components or processes co-activated by hyphae-inducing conditions are required. Thus, although the major pathways of morphogenesis, the functions of identified HSGs and several transcriptional factors have been studied, not all of the target genes of these transcriptional factors and their relationship to each other have been discovered [54] .
Difficulties in identifying and validating the functions of putative HSGs and other genes were attributed to the diploid genome of C. albicans, therefore, the genetics of Saccharomyces cerevisiae was useful to provide clues to morphogenesis in C. albicans [55] . Recent advances in molecular technology have made genetic and proteomic studies of C. albicans more effective. However, until now, the search for the elusive hypothetical initiator or 'master' gene(s) controlling the cascade of events in morphology switching remains ongoing. Biofilms C. albicans biofilms consist of a complex, yet organized, structure of yeast and filamentous cells encased in a selfproduced extracellular matrix [56] . Biofilms, with their elaborate architecture, contribute to the difficulty in treating patients with systemic infections by having a higher resistance to both antifungal drugs and the host immune response, and also by causing the failure of in-dwelling medical devices [9] . These devices, such as catheters and heart valves, provide suitable surfaces for adhesion and the subsequent anchoring of biofilms [9, 56, 57] .
The ability of this fungus to undergo morphology switching from the yeast form to the hyphae form is critical for successful biofilm formation [58, 59 ], yet, current understanding of the molecular mechanisms regulating morphology switching and biofilm formation is still limited.
Quorum sensing
Quorum sensing is the phenomenon of cell-cell signaling or cell-cell communication in microorganisms. Quorum sensing uses extracellular signal molecules to mediate interactions between its producer and the surrounding chemical and physical environment, as well as with other microorganisms. The existence of quorum sensing in prokaryotes has been studied extensively, but quorum sensing research in eukaryotes, especially in the medically important diploid fungi Candida spp., has gained momentum only recently.
The interest in fungal quorum sensing stemmed from the unrequited observation that cell morphology is dependent on the initial cell inoculum density. This phenomenon, in fungi capable of yeast-filament transition, has been termed the inoculum size effect [60] . Under identical culture conditions, germ tubes and mycelia were produced when <10 6 cells/mL were inoculated, whereas predominantly budding yeasts grew at >10 6 cells/mL of inocula [60] . Lingappa et al. [61] were among the first to describe the link between quorum sensing and morphogenesis. They described two isolated compounds, 2-phenylethanol and tryptophol, called 'autoantibodies', which seemed to be fungistatic and block filamentation. However, these two compounds, which might have been the first C. albicans quorum-sensing molecules (QSMs), were required to be present at high levels (above 500 μmol/L) to block filamentation [62] . The involvement of these two compounds in morphology switching remains to be thoroughly studied. Hazen and Cutler [62, 63] also characterized another filament-inhibiting compound, termed morphogenic autoregulatory substance (MARS), of which much is still not known.
Farnesol was the first true QSM to be discovered in an eukaryotic system [64] . This compound is able to block filamentation induced by the environmental signals for most signaling pathways activating hyphae development. These signals include 10% serum, 10 mM L-proline, 2.5 mM N-acetylglucosamine, or the combination of Nacetylglucosamine and L-proline, all at 37°C [64] .
While the aforementioned substances were involved in inhibiting yeast-hyphae transition, another C. albicans QSM, tyrosol, was found to promote hyphae development by shortening the lag-time of cells to begin germinating in hyphae-inducing conditions [65] . However, Nickerson et al. [66] indicated that tyrosol is a minor QSM whose effects are only observed when little or no farnesol is present in the environment.
Hogan et al. [67] suggested that 12-carbon backbone (C12) molecules, which are structurally related to farnesol, could affect C. albicans in the same way. The Pseudomonas aeruginosa QSM, 3-oxo-C12 homoserine lactone (3OC12HSL), another C12 molecule, 1-dodecanol [67] , and the synthetic C12 molecule 2-dodecanol [68] completely inhibited C. albicans filamentation without influencing cellular growth rates.
In C. albicans, the presence of farnesol also explains why germ tube and hyphae studies at 37°C can only be carried out at cell densities of ≤10 7 cells/mL [64] and, together with other QSMs, elucidate the phenomenon of the inoculum size effect. There are, undoubtedly, more QSMs inherently produced by C. albicans which have yet to be described, whose discovery would be instrumental in contributing to a better understanding of C. albicans.
Recent studies have shown that C. albicans strains 'locked' into either the yeast or hyphal forms were found to have reduced virulence in mouse models of systemic candidiasis [42, 50, 69] . Therefore, there are other factors which induce virulence during yeast-hyphae switching that are not present when only either the yeast or hyphae forms was present.
A study by Hornby and Nickerson [70] found that a predominantly yeast population, with higher levels of farnesol production, was produced after Candida were treated with sublethal concentrations of azoles. C. albicans cells with this pretreatment in a mouse infection model were found to exhibit a dramatic increase in virulence [71] . In this way, farnesol was correlated with virulence for the first time. Navarathna et al. [72] also demonstrated that the addition of exogenous farnesol increased the virulence of wild-type C. albicans in a mouse model of infection. They also showed that a DPP3 gene null mutant strain, which is defective in farnesol production, resulted in the attenuation of virulence in the same model. Exogenous farnesol even restored the virulence of the dpp3 mutant [73] .
Initially, it was thought that QSMs such as farnesol could be manipulated to treat invasive candidiasis as a fungistatic agent [64] , but the discovery that endogenous farnesol actually contributed to C. albicans virulence has redirected recent research into understanding QSMs as an important new virulence factor of systemic candidiasis.
The results from a study by Davis-Hanna et al. [74] suggested that farnesol and dodecanol inhibited components of the Ras1-Cdc35-PKA-Efg1 pathway, causing the repression of hyphae formation in C. albicans. This was the first study implicating how QSMs may function as regulators of morphogenesis. The Ras1-cAMP-Efg1 signaling cascade (Fig. 2) , also known as the Ras1-Cdc35 (adenylate cyclase)-PKA-Efg1 pathway, seems to be especially important for C. albicans virulence in animal models of invasive candidiasis [42, 75] . This pathway controls hyphae development in response to multiple stimuli, including N-acetyl-D-glucosamine (GlcNAc), serum, and glucose [52, 76, 77] . Adenylate cyclase is stimulated by activated small GTPase Ras1, leading to a cAMP signal promoting PKA-mediated activation of transcription factor(s), such as Efg1, which mediate yeast-hyphae morphogenesis [52, 78, 79] . In a nutshell, these studies on QSMs showed that, although morphology switching has long been viewed as the dominant virulence factor above all others, without doubt, more research findings will emerge on the involvement of the quorum-sensing mechanism in virulence.
C. albicans invasion of the host endothelial barrier
In the healthy host, the epithelial and endothelial layers and the innate defense systems are barriers preventing the three major steps in establishing a fungal infection in the susceptible host: fungal proliferation, colonization, and invasion. C. albicans already applies various strategies to survive as a commensal within the host, but takes advantage of a compromised barrier by deploying infectious strategies, such as yeast-hyphae morphology switching [80] . Odds [81] hypothesized that, during the establishment and progression of C. albicans infections, the role of specific virulence factors as well as host response vary with time and magnitude of infection.
Fradin et al. [82] reported that C. albicans is able to modify its global expression levels within 10 min of contact with human blood, mostly in response to granulocytes. This demonstrates that the success of C. albicans as a pathogen comes with its ability to quickly adapt to changing environments, such as at infection sites and to host responses [80] .
A model suggesting how C. albicans establishes a hematogenously disseminated infection has been developed, as reviewed by Grubb et al. [83] and Orozco et al. [84] , where the following events unfold: C. albicans cells likely invade the bloodstream through surfaces where the epithelial layer is compromised, i.e., via surgical sites and wounds, through contaminated intravascular devices, or by presorption across the gastrointestinal mucosa. C. albicans cells in the bloodstream then adhere to the endothelial cell lining of blood vessels and transmigrate into the tissues. Once in the endothelial cells, the organisms go on to injure and eventually kill the cells, gaining entrance to the deep tissues.
Currently, two distinct theories exist as to how C. albicans adheres to the endothelium (reviewed by Grubb et al. [83] ). The first suggests that cells convert from yeast to hyphae, which then bind and cause injury to the endothelial vasculature before transmigration. Another theory proposes that it is the yeast cells that adhere to the endothelium and transmigrate into the tissues without switching to hyphal forms. Nevertheless, both theories agree that yeast-hyphae switching is necessary for tissue damage leading to cell death.
The process of transmigration from the bloodstream into the tissues is difficult to study in the laboratory. Nevertheless, one of several theories using adhesion mechanisms suggests that adherent fungal cells which are endocytosed make their way to the abluminal surface of the endothelial cell layer [85, 86] . The second theory proposes that hyphae penetrates through the endothelial cells, while another suggests that adherent C. albicans cells pass between adjacent endothelial cells, resembling leukocyte and tumor cell trans-endothelial cell migration [83] . Hypotheses for non-adhesion transmigration mechanisms include the proposal that leukocytes transport phagocytosed organisms [87] and that circulating Candida travel between adjacent endothelial cells in vascular beds, such as in the kidney. Phagocytic cells, especially macrophages and neutrophils, are apparently crucial in host defense against invading C. albicans, as the majority of candidal infections affect patients with neutropenia or defects in neutrophil or macrophage functions (reviewed by Grubb et al. [83] ).
Previous studies have suggested that, in general, the proinflammatory (anti-Candida) response is important in purging the initial candidal infection [84] . Villar et al.
[88] used enzyme-linked immunosorbent assay (ELISA)-based cytokine arrays to investigate endothelial cell response to infection by an invasion-deficient strain (RIM101 mutant) of C. albicans and two highly invasive strains. They found that the highly invasive strains triggered a stronger pro-inflammatory response than the invasiondeficient mutant.
Internalized, live, germinated C. albicans organisms induced higher productions of the interleukins IL6 and IL8, the leukocyte adhesion molecules E-selectin, ICAM-1 and VCAM-1, GRO, granulocyte stimulating factor (G-CSF), and the monocyte chemoattractant proteins MCP-1 and MCP-2 [84, 88] . When epithelial cells were used as the 'host', IL1α, IL6, IL8, and TNFα levels were found to be significantly higher in the invasive versus the non-invasive strain [88] . Another group infected endothelial cells with the homozygous null mutants for CLA4, CPH1, EFG1, and TUP1. Phan et al. [89] reported that all of the null mutants had reduced invasion and injury capabilities.
Barker et al. [90] investigated the cDNA microarray transcriptome profile of endothelial cells in response to the wild type and hypovirulent CPH1/EFG1 double homozygous null mutant. This study was, essentially, a study of the response of endothelial cell genes to the yeast (knockout mutant) and hyphal (wild type) forms. A global response was elucidated, where many genes functioning in apoptosis, immune response, signal transduction, response to stress, and others were significantly upregulated at higher magnitudes in the endothelial cells cultured with the invasive phenotype compared to cells cultured with the non-invasive phenotype.
Monocyte-C. albicans co-cultures were studied by Kim et al. [91] and Barker et al. [92] , where, again, the invasive form of the fungus elucidated higher expression levels of genes involved in immune response, apoptosis, and others, compared to the non-invasive, hypovirulent form. Monocytes produced the macrophage inflammatory proteins MIP1α and MIP1β, RANTES, TNFα, and others in response to C. albicans infection [93] . In addition, IL1β, TNFα, and IL10 were produced in response to hyphal cells, but IL12 was produced in response to cells which were unable to form hyphae [94] [95] [96] .
Although the host cytokine response to Candida infection is generally 'protective', there is growing evidence that this is not generalizable, as the immune response is possibly site-specific and compartmentalized [97, 98] . A report by van der Graaf et al. [99] suggested that host cells are stimulated differently by heat-killed blastoconidia and hyphae of C. albicans. Using human and murine peripheral blood mononuclear cells (PBMC), the authors found that the blastoconidia stimulated both TLR2 and TLR4 (Tolllike receptors), where TLR4 is responsible for IFNγ production. However, although hyphae induced higher levels of IL10 through TLR2, TLR4 did not recognize hyphae, and, therefore, did not produce IFNγ [99] . In addition, the IL10 released through TLR2 is lethal in experimental models of systemic candidiasis [100] .
As IFNγ is an important part of the pro-inflammatory response against C. albicans infection, hyphae germination may cause a loss of IFNγ presence, thereby, suppressing the pro-inflammatory response, making the yeast-hyphae morphology switching process an effective virulence mechanism [99] . The authors also proposed that C. albicans undergoes morphogenesis to escape the immune response. This suggests that the morphological form of C. albicans in an infection is also instrumental in influencing the host immune response.
Research has suggested that the fungal cells use different morphologies at different times in a variety of microenvironments within the host and that each form has its specific purpose in pathogenesis. Evans [101] found a higher, faster, and more consistent mortality rate in mice with blastospore infection compared to hyphae infection. The kidneys, as the most severely affected organ in systemic candidiasis, had very extensive blastospore growth, whereas the growth rate of inoculated hyphae were slow or were eliminated in this organ [101] . Through in vitro flow adhesion assays by Grubb et al. [102] , the authors found that the yeast, pseudohyphal, and hyphal forms of C. albicans rapidly adhered to endothelial cells, with the yeast forms binding in significantly greater numbers than the pseudohyphal or hyphal forms. These and other data by Bendel et al. [103] , Chen et al. [104] , Saville et al. [40] , and Spellberg et al. [105] suggest that yeast cells may adhere to the endothelium, transmigrate into the tissues, then undergo yeast-hyphae switching to cause tissue damage.
White et al. [106] put forward the hypothesis that C. albicans commensalism or pathogenesis may be interlinked with conditions in the host gastrointestinal tract, but it is still a hotly debated issue as to whether C. albicans must undergo the yeast-hyphae transition to transmigrate across the blood vessel endothelium into the tissues. Findings by Evans and Mardon [107] as well as MacCallum and Odds [108] support the idea that C. albicans need not undergo transition, while Rotrosen et al. [109] reported that C. albicans yeast cells were clearly found to rapidly transmigrate from the circulation (80-90% in 5 min), versus the several hours needed for yeast-hyphae transition to cause endothelial cell injury. Furthermore, a C. albicans mutant strain, locked into the yeast form, left the blood vessels for the tissues in greater numbers than the wild type control [103] . Finally, C. glabrata, C. tropicalis, and C. parapsilosis cannot form true hyphae, yet, are fast emerging as the next most common cause of disseminated candidiasis after C. albicans [11] .
All of the available findings point to the quorum-sensing mechanism as the ultimate virulence factor preceding morphology switching, SAP production, and other virulence factors involving hyphae formation. Thus far, the most well studied C. albicans QSM is farnesol, which has shown considerable potential to be critically involved in breaching the host endothelial barrier.
Free farnesol is not usually detected in human plasma [110] , probably because farnesol is lipophilic [64] , thus, favoring membrane localization and causing alterations in the membrane fluidity of host cells [64] , to create an entry site for C. albicans invasion. Farnesol could also reduce the production of diacylglycerol, a protein kinase C activator, thereby, inhibiting cell growth and resulting in apoptosis [111] . Skaar et al. [112] found that Staphylococcus aureus uses hemolysin to poke holes in host red blood cells for iron sequestration during infection. It has been suggested that farnesol may be used by C. albicans in a similar fashion [72] .
Quorum sensing controls morphology switching, and, therefore, may be upstream of all hyphae-associated events. The puzzle of C. albicans pathogenic events may finally be pieced together by the discovery of the quorum-sensing mechanism of environmental adaptation as a virulence factor, therefore, aiding the elucidation of the pathogenic cascade.
Conclusion
In summary, the increase of invasive candidiasis as a nosocomial infection with treatment complications is alarming. This warrants further investigations in order to understand the complex mechanisms and processes involving the Candida albicans quorum-sensing mechanism, pathogenesis, and host environment in invasive colonization. In addition, studying the conditions in host niches which can spark Candida pathogenesis in further detail would be interesting, and may prove crucial to identifying new host-based prophylactic measures or treatments for C. albicans invasive candidiasis. 
